CompletedNot Applicable

SWT VERSUS EMFT IN KOA

Egypt60 participantsStarted 2025-01-01

Plain-language summary

The purpose of this study was to compare the effect of extracorporeal shock wave therapy and pulsed electromagnetic field in reducing pain, improving function, and increasing ROM in knee osteoarthritis patients.

Who can participate

Age range40 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Sixty patients must have a confirmed diagnosis of knee osteoarthritis, specifically those with mild to moderate osteoarthritis.
✓. Participants must have experienced knee pain lasting more than 3 months.
✓. Their ages will be ranged from 40 to 60 years.
✓. Their body mass index within the range of 22.7 to 28.5 kg/m² kg/m².
✓. Both male and female patients are eligible for the study.
✓. At least two positive provocative tests, such as joint line tenderness and crepitus, which are commonly associated with knee osteoarthritis.

Exclusion criteria

✕. Inflammatory arthritis (e.g., rheumatoid arthritis) or other forms of arthritis that are not osteoarthritis.
✕. Undergone knee replacement surgery or any significant knee surgery within the past year.
✕. Severe cardiovascular, respiratory, renal, or hepatic diseases that could interfere with study participation or outcomes.
✕. Received intra-articular corticosteroid injections in the affected knee within the last 3 months.
✕. Pregnant or breastfeeding due to the unknown effects of study treatments on fetal and infant development.
✕. Neurological conditions affecting the lower limbs (e.g., stroke, neuropathy). body mass index greater than 30 kg/m², as severe obesity may influence treatment outcomes and complicate assessment.
✕. Cognitive impairments or psychiatric conditions that may affect their ability to participate.

What they're measuring

Change in physical function.

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Change in pain intensity

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Change in range of motion.

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Trial details

NCT IDNCT07505368

SponsorSuez Canal University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Physical Therapy trials

Who can participate

Age range40 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Sixty patients must have a confirmed diagnosis of knee osteoarthritis, specifically those with mild to moderate osteoarthritis.
✓. Participants must have experienced knee pain lasting more than 3 months.
✓. Their ages will be ranged from 40 to 60 years.
✓. Their body mass index within the range of 22.7 to 28.5 kg/m² kg/m².
✓. Both male and female patients are eligible for the study.
✓. At least two positive provocative tests, such as joint line tenderness and crepitus, which are commonly associated with knee osteoarthritis.

Exclusion criteria

✕. Inflammatory arthritis (e.g., rheumatoid arthritis) or other forms of arthritis that are not osteoarthritis.
✕. Undergone knee replacement surgery or any significant knee surgery within the past year.
✕. Severe cardiovascular, respiratory, renal, or hepatic diseases that could interfere with study participation or outcomes.
✕. Received intra-articular corticosteroid injections in the affected knee within the last 3 months.
✕. Pregnant or breastfeeding due to the unknown effects of study treatments on fetal and infant development.
✕. Neurological conditions affecting the lower limbs (e.g., stroke, neuropathy). body mass index greater than 30 kg/m², as severe obesity may influence treatment outcomes and complicate assessment.
✕. Cognitive impairments or psychiatric conditions that may affect their ability to participate.

What they're measuring

Change in physical function.

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Change in pain intensity

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.

Change in range of motion.

Timeframe: Pretreatment measurement and posttreatment (4 weeks) measurement.